← Browse by Condition
Medical Condition

metastatic cholangiocarcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06160752 Phase 1
Recruiting

Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations

Enrollment
40 pts
Location
United States
Sponsor
Tyra Biosciences, Inc
View Trial →